Ticker Hub
BSX — AI Analysis & Sentiment
7 recent AI-generated analyses for BSX. Sentiment and confidence insights updated continuously.
FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints
Boston Scientific's successful FRACTURE IDE trial significantly de-risks the SEISMIQ 4CE catheter, paving the way for regulatory approval and marke...
May 19, 2026Boston Scientific announces strategic investment in MiRus LLC
Boston Scientific's strategic investment in MiRus and option to acquire its TAVR technology positions the company for future growth in cardiovascul...
May 18, 2026Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
Boston Scientific reported strong clinical trial results for core cardiovascular devices, reinforcing their effectiveness and market potential. Thi...
Apr 26, 2026Boston Scientific announces results for first quarter 2026
Boston Scientific's strong Q1 2026 earnings beat and positive product pipeline developments present a potential buying opportunity, especially give...
Apr 22, 2026CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
Boston Scientific's successful clinical trial for its WATCHMAN FLX device positions it for significant market expansion. This development could sub...
Mar 28, 2026HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
Boston Scientific's EKOS system demonstrated superiority in clinical trials for acute pulmonary embolism, representing a significant medical advanc...
Mar 28, 2026Ongoing Investigation: Boston Scientific Corporation (BSX) May Have Misled Shareholders - Levi & Korsinsky Investigates
Boston Scientific faces new legal risk from a shareholder investigation related to its Q4 2025 earnings, specifically concerning its underperformin...
Feb 20, 2026